Canaccord Genuity Maintains Buy on Exact Sciences, Raises Price Target to $95
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity has maintained a Buy rating on Exact Sciences and raised the price target from $75 to $95, indicating confidence in the company's future performance.
October 29, 2024 | 12:20 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Canaccord Genuity has increased its price target for Exact Sciences from $75 to $95, maintaining a Buy rating. This suggests a positive outlook for the company's stock.
The increase in price target from $75 to $95 by Canaccord Genuity, along with the maintained Buy rating, indicates strong confidence in Exact Sciences' future performance. This is likely to positively influence investor sentiment and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100